Please try another search
CVRx, Inc., a commercial-stage medical device company, focuses on developing, manufacturing, and commercializing neuromodulation solutions for patients with cardiovascular diseases. The company offers Barostim, a neuromodulation device indicated to improve symptoms for patients with heart failure with reduced ejection fraction or systolic heart failure. It sells its products through direct sales force, as well as sales agents and independent distributors in the United States, Germany, and internationally. The company was incorporated in 2000 and is headquartered in Minneapolis, Minnesota.
Name | Age | Since | Title |
---|---|---|---|
Joseph P. Slattery | 59 | 2008 | Independent Director |
Kevin Hykes | 58 | 2022 | President, CEO & Director |
Mudit K. Jain | 55 | 2020 | Independent Director |
Martha Shadan | 69 | 2021 | Independent Director |
Kirk G. Nielsen | - | 2020 | Independent Director |
Mitchell C. Hill | 65 | 2024 | Director |
Kevin J. Ballinger | 51 | 2024 | Director |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review